PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Endocrine and toxic myopathies (Chapter 24) - Disorders of Voluntary Muscle

JCM, Free Full-Text

Coenzyme Q10 and Statin Myalgia: What is the Evidence?

Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment, Lipids in Health and Disease

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia

Atherogenic dyslipidemia in Latin America: prevalence, causes and treatment. Consensus

Vitamins

Frontiers Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?

PDF) Statin-induced myopathy: A review and update

Full article: Statin-induced myopathy: a review and update

Regulatory Effects and Molecular Mechanisms of Tea and Its Active Compounds on Nonalcoholic Fatty Liver Disease